Business_Finance

martin_shkreli_trial_75124.jpg

Martin Shkreli, center, leaves federal court in New York, Friday, Aug. 4, 2017. The former pharmaceutical CEO has been convicted on federal charges he deceived investors in a pair of failed hedge funds. A Brooklyn jury deliberated five days before finding Shkreli guilty on Friday on three of eight counts. (AP Photo/Seth Wenig)

martin_shkreli_trial_78968.jpg

Martin Shkreli, center, leaves federal court in New York, Friday, Aug. 4, 2017. Shkreli, the eccentric former pharmaceutical CEO notorious for a price-gouging scandal and for his snide "Pharma Bro" persona on social media, was convicted Friday on federal charges he deceived investors in a pair of failed hedge funds. (AP Photo/Seth Wenig)

martin_shkreli_trial_78692.jpg

Martin Shkreli arrives at federal court in New York, Friday, Aug. 4, 2017. Jurors are starting their fifth day of deliberations at the federal securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Seth Wenig)

martin_shkreli_trial_78138.jpg

Martin Shkreli arrives at federal court in New York, Friday, Aug. 4, 2017. Jurors are starting their fifth day of deliberations at the federal securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Seth Wenig)

martin_shkreli_trial_12718.jpg

Martin Shkreli arrives at federal court in New York, Friday, Aug. 4, 2017. Jurors are starting their fifth day of deliberations at the federal securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Seth Wenig)

martin_shkreli_trial_43898.jpg

Martin Shkreli arrives at federal court in New York, Friday, Aug. 4, 2017. Jurors are starting their fifth day of deliberations at the federal securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Seth Wenig)

martin_shkreli_trial_07441.jpg

Martin Shkreli arrives at federal court in New York, Thursday, Aug. 3, 2017. Jurors are starting their fourth day of deliberations at the federal securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Seth Wenig)

martin_shkreli_trial_40046.jpg

Former pharmaceutical company CEO Martin Shkreli, second from left, walks out of federal court with his legal team Thursday, Aug. 3, 2017, in New York. Jurors were on their fourth day of deliberations Thursday at the securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Julie Jacobson)

martin_shkreli_trial_76591.jpg

Former pharmaceutical company CEO Martin Shkreli stands at an intersection after leaving federal court with his legal team, Thursday, Aug. 3, 2017, in New York. Jurors were on their fourth day of deliberations on Thursday at the securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Julie Jacobson)

martin_shkreli_trial_15039.jpg

Former pharmaceutical company CEO Martin Shkreli, center, walks out of federal court with members of his legal team, Thursday, Aug. 3, 2017, in New York. Jurors were on their fourth day of deliberations on Thursday at the securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Julie Jacobson)

martin_shkreli_trial_62090.jpg

Former pharmaceutical company CEO Martin Shkreli, center, walks out of federal court with members of his legal team Thursday, Aug. 3, 2017, in New York. Jurors were on their fourth day of deliberations on Thursday at the securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Julie Jacobson)

martin_shkreli_trial_82566.jpg

Former pharmaceutical company CEO Martin Shkreli, right, walks out of federal court with members of his legal team, Thursday, Aug. 3, 2017, in New York. Jurors were on their fourth day of deliberations on Thursday at the securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Julie Jacobson)

martin_shkreli_trial_36936.jpg

Former pharmaceutical company CEO Martin Shkreli, left, walks out of federal court with his attorney Benjamin Brafman, Thursday, Aug. 3, 2017, in New York. Jurors were on their fourth day of deliberations Thursday at the securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Julie Jacobson)

japan_toyota_mazda_24185.jpg

Toyota Motor Corp. President Akio Toyoda, left, and Mazda Motor Corp. President Masamichi Kogai, pose for media prior to a press conference in Tokyo Friday, Aug. 4, 2017. Japanese automakers Toyota Motor Corp. and Mazda Motor Corp. said Friday they plan to spend $1.6 billion to set up a joint-venture auto manufacturing plant in the U.S. — a move that will create up to 4,000 jobs. (AP Photo/Eugene Hoshiko)

japan_toyota_mazda_52559.jpg

Logos of Toyota Motor Corp., bottom, and Mazda Motor Corp., top, are placed prior to a press conference in Tokyo Friday, Aug. 4, 2017. (AP Photo/Eugene Hoshiko)

japan_toyota_mazda_86187.jpg

Toyota Motor Corp. President Akio Toyoda, left, and Mazda Motor Corp. President Masamichi Kogai shake hands after a press conference in Tokyo Friday, Aug. 4, 2017. Japanese automakers Toyota Motor Corp. and Mazda Motor Corp. said Friday they plan to spend $1.6 billion to set up a joint-venture auto manufacturing plant in the U.S. — a move that will create up to 4,000 jobs. (AP Photo/Eugene Hoshiko)

japan_toyota_mazda_65605.jpg

Toyota Motor Corp. President Akio Toyoda, left, and Mazda Motor Corp. President Masamichi Kogai answer a question during a press conference in Tokyo Friday, Aug. 4, 2017. Japanese automakers Toyota Motor Corp. and Mazda Motor Corp. said Friday they plan to spend $1.6 billion to set up a joint-venture auto manufacturing plant in the U.S. — a move that will create up to 4,000 jobs. (AP Photo/Eugene Hoshiko)

japan_toyota_mazda_56107.jpg

Staffs explain to journalists at the stage for a joint presser of Toyota Motor Corp. , left, and Mazda Motor Corp. , right, prior to a press conference in Tokyo Friday, Aug. 4, 2017. Japanese automakers Toyota Motor Corp. and Mazda Motor Corp. said Friday they plan to spend $1.6 billion to set up a joint-venture auto manufacturing plant in the U.S. — a move that will create up to 4,000 jobs. (AP Photo/Eugene Hoshiko)

japan_toyota_mazda_45113.jpg

Toyota Motor Corp. President Akio Toyoda, left, and Mazda Motor Corp. President Masamichi Kogai, right, bow to each other prior to a press conference in Tokyo Friday, Aug. 4, 2017. Japanese automakers Toyota Motor Corp. and Mazda Motor Corp. said Friday they plan to spend $1.6 billion to set up a joint-venture auto manufacturing plant in the U.S. — a move that will create up to 4,000 jobs. (AP Photo/Eugene Hoshiko)

japan_toyota_mazda_41854.jpg

Toyota Motor Corp. President Akio Toyoda, left, and Mazda Motor Corp. President Masamichi Kogai, right, pose for media prior to a press conference in Tokyo Friday, Aug. 4, 2017. Japanese automakers Toyota Motor Corp. and Mazda Motor Corp. said Friday they plan to spend $1.6 billion to set up a joint-venture auto manufacturing plant in the U.S. — a move that will create up to 4,000 jobs. (AP Photo/Eugene Hoshiko)